Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy
Current strategies to boost anti-tumor immune response include the use of immune checkpoint inhibitors and bispecific T cell-engaging antibodies. Here the authors describe a versatile antibody immobilization nanoplatform that can be used to deliver different combinations of immunotherapeutics, showi...
Guardado en:
Autores principales: | Cheng-Tao Jiang, Kai-Ge Chen, An Liu, Hua Huang, Ya-Nan Fan, Dong-Kun Zhao, Qian-Ni Ye, Hou-Bing Zhang, Cong-Fei Xu, Song Shen, Meng-Hua Xiong, Jin-Zhi Du, Xian-Zhu Yang, Jun Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/df1fd3f94ada4483a1c1ec207bb754dd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- Monoclonal antibodies in immunodiagnosis and immunotherapy
-
Beyond HAT Adaptor: TRRAP Liaisons with Sp1-Mediated Transcription
por: Bo-Kun Yin, et al.
Publicado: (2021) -
Nano-bio interfaces effect of two-dimensional nanomaterials and their applications in cancer immunotherapy
por: Zhongmin Tang, et al.
Publicado: (2021) -
EUDOGENOUS AND EXOGENOUS IMMUNOMODULATORS
por: Editorial article
Publicado: (2014) -
EUDOGENOUS AND EXOGENOUS IMMUNOMODULATORS
por: Editorial article
Publicado: (2014)